Exporters disappointed as Budget 2025 fails to address Section 43B(h) waiver demand: Shardul Nautiyal, Mumbai Wednesday, February 5, 2025, 08:00 Hrs [IST] India's pharmaceutical e ...

Congress nearly passed legislation to restrict pharmacy benefit manager business practices at the end of 2024.

Union Minister of State for Chemicals and Fertilizers, Smt. Anupriya Patel, provided these updates in a written reply in the Rajya Sabha today, underscoring India’s commitment to affordable medicines ...

The National Pharmaceuticals Pricing Policy, 2012 (NPPP, 2012) lays down the regulatory framework for pricing of drugs.This information was given by the Union Minister of State ...

The new EU compass could support small companies to grow their market share across Europe, assisted by fewer regulatory ...

Diabetic Macular Edema MarketThe global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to ...

Our Bureau, Mumbai Friday, January 31, 2025, 16:15 Hrs [IST] PharmaTech Expo 2025 & LabTech Expo 2025, held from January 8 to 10, 2025 a ...

The 7th International Digital Almaty Forum gathered global tech leaders, officials, and investors for an extensive program ...

Fructosamine Test IndustryThe global fructosamine test indutry was valued at around USD 266.3 million in 2023 and is poised to exhibit a CAGR of 3.8% during the forecast period. Accordingly, total ...

Six other drugs will have a concessional customs duty of 5% as part of efforts to increase accessibility of expensive advanced medicines for a larger section of patients ...

Manufacturing Technology (Precision Fermentation, Enzymatic Conversion, Chemical Synthesis), Application, Form, Source, ...